INS and diabetes mellitus: Results revealed that non-canonical Wnt5a signaling and JNK activity correlated with vascular reluctance to insulin action and to induce endothelial dysfunction, thus offering a novel therapeutic opportunity to protect the vasculature in patients with diabetes mellitus [57].